Phase II trial of pembrolizumab, ipilimumab, and aspirin in melanoma: clinical outcomes and translational predictors of response
Article in BJC Reports (June 2024)
The most recent citing publications are shown below. View all 71 publications that cite this research output on Dimensions.
Clinicopathological features of kidney injury in patients receiving immune checkpoint inhibitors (ICPi) combined with anti-vascular endothelial growth factor (anti-VEGF) therapy
Article in Journal of Clinical Pathology (January 2024)
Preoperative immune checkpoint inhibition and cryoablation in early-stage breast cancer
Article in iScience (January 2024)